Privium Fund Management B.V. - 11 Dec 2025 SCHEDULE 13G Report for ProQR Therapeutics N.V. Ordinary Shares, nominal value EUR0.04 per share (PRQR)

Filing Manager: Privium Fund Management B.V.
Reporting Manager: PATRICK JOHAN HENDRIK KROL
Security: ProQR Therapeutics N.V. Ordinary Shares, nominal value EUR0.04 per share
Symbol: PRQR
Shares outstanding: 106,324,269 shares
Disclosed Ownership: 5,528,862 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 20 Jan 2026, 17:21:56 UTC
Date of event: 11 Dec 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
STICHTING AESCAP LIFE SCIENCES	3.9%	4,156,878	4,156,878	/s/ P.J.H. Krol	P.J.H. Krol, Portfolio Manager of Privium Fund Management B.V., its Fund Manager
PRIVIUM FUND MANAGEMENT B.V.	5.2%	5,467,149	5,467,149	/s/ P.J.H. Krol	P.J.H. Krol, Portfolio Manager
STICHTING AESCAP GENETICS	1.2%	1,310,271	1,310,271	/s/ P.J.H. Krol	P.J.H. Krol, Portfolio Manager of Privium Fund Management B.V., its Fund Manager
INSPIRATIONAL VISIONS B.V.	0.1%	35,411	35,411	/s/ P.J.H. Krol	P.J.H. Krol, Managing Director
PATRICK JOHAN HENDRIK KROL	5.2%	5,528,862	5,528,862	/s/ P.J.H. Krol	P.J.H. Krol